Presentations , November 03-04 2023
Welcome and Introduction, Ryan Fitzpatrick, Joana Torres & Millie Long
Session I: Optimizing Biologic Therapies in IBD
Moderator: Millie Long & Paula Ministro
Anti-TNF therapy in IBD (including biosimilars)
Joana Torres, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
Anti-integrin therapy in IBD
Paula Ministro, Tondela-Viseu Hospital Center, Viseu, Portugall
IL-23 therapies in IBD
Triana Lobaton, Ghent University Hospital, Ghent, Belgium
Panel Discussion
Session II: Focus on small molecules in IBD
Moderator: Joana Torres
Conventional immunomodulator therapy in IBD – still a role in the armamentarium?
Naila Arebi, St. Mark’s Hospital, Harrow, Middlesex, UK
JAK Inhibitors in IBD: Does selectivity matter?
Séverine Vermeire, Leuven, Belgium
S1P Inhibitors in IBD – how do they work and how to use them?
Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
Panel Discussion
Independent Expert Discussion supported by Pfizer
Session III: Women’s health in IBD
Moderator: Séverine Vermeire
Contraceptive and Pre-Conception Counseling in IBD: the role of the Gastroenterologist
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
Pregnancy and IBD
Mette Julsgaard, Aarhus University Hospital, Aarhus, Denmark
Post Delivery: Implications for Mum and Baby
Sophie Restellini, Hôpital de La Tour, Switzerland
Panel Discussion
Session IV: Medical and surgical management of IBD
Moderators: Millie Long & Joana Torres
Non-invasive monitoring of IBD
Federica Furfaro, IRCCS San Raffaele Hospital
Treat to Target in IBD – too much or too little?
Ana Guttierrez, Hospital General Universitario de Alicante
Surgical Management of the female IBD patient
Susana Ourô, Hospital Beatriz Ângelo & Hospital da Luz, Portugal
Panel discussion & Take-home points from day 1, Millie Long & Joana Torres
Session V: Lifespan of IBD
Moderator: Marla Dubinsky
Successful Mentorship: A Guide for Mentees and Mentors,
Britta Siegmund, Universitätsmedizin Berlin, Berlin, Germany
A Pathway to Leadership for Women in GI: Lessons Learned
Marla C. Dubinsky, Icahn School of Medicine Mount Sinai New York
Panel Discussion
Session VI: Positioning of Therapies in IBD
Moderator: Joana Torres
Disease location and Severity: Considerations for Positioning of Therapies
Charlotte Hedin, Karolinska University Hospital in Stockholm, Sweden
Safety Considerations for Positioning of Therapies
Millie Long, University of North Carolina,Chapel Hill, North Carolina, USA
Management of Pouchitis in 2023: From Antibiotics to Biologics,
Millie Long University of North Carolina,Chapel Hill, North Carolina, USA
Panel Discussion
Independent Expert Discussion supported by Celltrion
Session VII: Lifespan of IBD
Moderators: Marla C. Dubinsky
Considerations for the Management of Pediatric IBD
Lissy de Ridder, The Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands
Sexuality in the IBD patient
Joana Roseira, Centro Hospitalar do Algarve, Portugal
Considerations for Management of IBD in Older Individuals
Daniela Pugliese, CEMAD - IBD UNIT Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy